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Abstract
P2X7 is an ATP-gated ion channel that is highly expressed by leukocytes, such as macrophages. Here, P2X7 has been
demonstrated to be involved in the regulation of various cell death pathways; including apoptosis, pyroptosis,
necrosis, and autophagy. However, cell death induction via P2X7 is complex and is reliant upon the nature of the
stimulus, the duration of the stimulus, and the cell type investigated. Previous reports state that high extracellular ATP
concentrations promote osmotic lysis, but whether positive allosteric modulation of P2X7 in the presence of lower
concentrations of ATP condemns cells to the same fate is unknown. In this study, we compared cell death induced by
high ATP concentrations, to cell death induced by compound K, a recently identified and potent positive allosteric
modulator of P2X7. Based on our observations, we propose that high ATP concentrations induce early cell swelling,
loss of mitochondrial membrane potential, plasma membrane rupture, and LDH release. Conversely, positive allosteric
modulation of P2X7 primarily promotes an intrinsic apoptosis pathway. This was characterised by an increase in
mitochondrial Ca2+, accelerated production of mitochondrial ROS, loss of mitochondrial membrane permeability in a
Bax-dependent manner, the potential involvement of caspase-1, and caspase-3, and significantly accelerated kinetics
of caspase-3 activation. This study highlights the ability of positive allosteric modulators to calibrate P2X7-dependent
cell death pathways and may have important implications in modulating the antimicrobial immune response and in
the resolution of inflammation.
Introduction
P2X7 is an ATP-gated ion channel expressed pre-
dominantly on immune cells such as macrophages. Here,
it plays key roles within inflammation via the activation of
the NLRP3-caspase-1 inflammasome, release of pro- and
anti-inflammatory mediators (e.g. IL-1β, IL-18, Annexin
A1), shedding of transmembrane proteins (i.e. CD62L,
CD23), and regulation of cell death processes (necrosis,
apoptosis, pyroptosis, autophagy)1. To date, the involve-
ment of P2X7 in regulating cell death has proven to be
complex and varied, and is governed by the cell type,
nature of the stimulus, and duration of the stimulus2.
Prolonged activation of P2X7 has been linked to typical
morphological changes during apoptosis, such as cell
blebbing, cell shrinkage, nuclear fragmentation, and
chromatin condensation3. Moreover, P2X7 can regulate
cell death via caspase-8 and caspase-9; stimulating ROS
production, mitochondrial dysfunction, cytochrome c
release, and caspase-3/7 activation3–6. Conversely, P2X7
can also activate the canonical (caspase-1 dependent)
pyroptosis pathway in LPS-primed cells. Here, ATP can
function as a damage-associated molecular pattern
(DAMP), resulting in cell blebbing, cytoplasmic swelling,
release of cytokines and alarmins, and ultimately lytic cell
death7–10. Furthermore, ATP can activate the non-
canonical pyroptosis pathway following LPS priming. In
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this pathway caspase-11 in mice, or caspase-4 and -5 in
humans, can partially cleave pannexin-1 channels,
resulting in K+ efflux and release of ATP into the extra-
cellular space11.
P2X7 is therefore an attractive target to manipulate cell
death pathways in scenarios where the type of death is
important; for example, during cancer, or following
infection with intracellular pathogens such as Myco-
bacterium tuberculosis or Toxoplasma gondii12. More-
over, cancer cells and pathogens can subvert the immune
response by employing the use of ectonucleotidases such
as CD39 and CD73 to limit the availability of ATP, or by
pathogens hiding within cells to evade recognition by host
immune receptors13,14. Therefore, the ability to enhance
or accelerate P2X7-dependent cell death pathways in
these scenarios could prove critical in the resolution of
infection or inflammatory situations.
One way in which the activity of P2X7 can be modified
is via allosteric modulation. We recently identified a
novel positive allosteric pocket within the central vesti-
bule of human P2X7 that is potentiated by ‘steroid-like’
triterpenoid glycosides, termed ginsenosides15,16. Parti-
cularly, compound K (CK), an in vivo metabolite from the
medicinal herb Panax ginseng had a profound effect on
P2X7-dependent responses and could potentiate ATP-
induced channel opening at nanomolar concentrations15.
Moreover, CK could enhance Ca2+ signalling, formation
of the macropore, and enhance cell death of macrophages
to a non-lethal concentration of ATP15. However, the
mechanism of cell death regulated by P2X7 in the pre-
sence of positive allosteric modulators is currently
unknown.
Our aim in this study was to compare the effects of high
ATP concentrations or positive allosteric modulation by
CK on the induction of P2X7-dependent cell death path-
ways and elucidate the cell death mechanism employed in
murine macrophages. We describe a mechanism whereby
positive allosteric modulation of P2X7 primarily promotes
an intrinsic apoptosis pathway, characterised by an
increase in mitochondrial Ca2+, accelerated production of
mitochondrial ROS, loss of mitochondrial membrane
permeability in a Bax-dependent manner, the potential




Mouse macrophage cell line J774.2 (obtained from
ECACC General Cell Culture Collection, UK) were
maintained in RPMI-1640 media containing L-glutamine
(Life Technologies, Fisher Scientific, UK) supplemented
with 10% foetal bovine serum (Sigma US origin, F2442)
and 100 U/ml penicillin plus 100 µg/mL streptomycin
(Fisher Scientific, UK). Cells were maintained at 37 °C in a
humidified incubator supplied with 5% CO2. Cells were
not tested for mycoplasma contamination.
For cell stimulations, stock ATP (A7699, Sigma–Aldrich,
UK) was prepared as a solution of 100mM in distilled
water and pH was corrected to 7.4 with 5M NaOH. Ali-
quots were frozen at −20 °C and used once. Ginsenoside
CK (CAS#39262-14-1, purity >98%) was from Chemfaces,
China and was prepared as 10mM stock in DMSO.
Flow cytometry
To quantify cell surface expression of murine P2X7
(mP2X7), 5 × 105 cells were pelleted prior to resuspension
in primary mouse anti-mouse P2X7 antibody (Hano43;
Enzo Life Sciences, UK) at a dilution of 1:20 in cold PBS/
0.5% BSA buffer. Cells were stained for 1 h on ice and then
washed with PBS/0.5% BSA buffer. This was followed by
staining with a goat anti-rat IgG Alexa488 secondary
antibody (Fisher Scientific, UK) at 1:100 dilution for 1 h on
ice. Following washing with PBS/0.5% BSA buffer, cells
were re-suspended in PBS/0.5% BSA buffer for acquisition
on a CytoFLEX flow cytometer (Beckman Coulter, USA;
laser excitation, 488 nm; emission detection, 533/30 nm).
Data were analysed using CytExpert software (Beckman
Coulter; version 2.1).
Dye uptake experiments
For YOPRO-1 dye uptake experiments cells were plated
at a density of 2 × 104 cells/well in complete RPMI 1640
media (100 µL per well) in poly-D-lysine coated 96-well
plates. Media was removed using a manual multichannel
pipette and replaced with a low divalent cation buffer
(145 mM NaCl, 2 mM KCl, 13 mM D-glucose, 10 mM
HEPES and 0.1 mM CaCl2, pH 7.3) containing 2 µM YO-
PRO-1 iodide (Life Technologies catalogue number
Y3663). For most experiments, ginsenosides (10 µM) were
co-injected simultaneously with the agonist using a
Flexstation 3 microplate reader (Molecular Devices, UK).
Ginsenosides and agonist were prepared at 10X final
concentration in the compound plate. Dye uptake over
time was recorded using an excitation wavelength of
488 nm and an emission wavelength of 520 nm on the
Flexstation 3 (6 reads/well, PMT setting medium). Basal
fluorescence measurements were acquired for 40 sec fol-
lowed by automatic injection of agonist and the kinetic
measurement of fluorescence intensity was performed for
300 sec using Softmax Pro v5.4 software (Molecular
Devices). Measurements were performed in triplicate and
repeated in three independent experiments. Dye uptake
responses were calculated as area under the curve from
50–300 sec using zero baseline normalised data.
Intracellular calcium measurements
For calcium measurements cells were plated at a density
of 2 × 104 cells/well in complete RPMI 1640 media
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(100 µL per well) in poly-D-lysine coated 96-well plates.
Cells were loaded with 2 µM Fura-2AM (Fisher Scientific)
in HBSS buffer containing 250 µM sulfinpyrazone
(Sigma–Aldrich, UK) for 40–60min at 37 °C. Following
loading, buffer was removed using a multichannel pipette
and replaced with standard extracellular buffer or low
divalent buffer. Cells were warmed for 10min before
measurements were started. Fura-2 was measured at
excitation wavelengths 340 nm and 380 nm with emission
wavelength 520 nm using a Flexstation 3 plate reader.
Sampling interval was 3.5 sec and 3 reads/well. Basal
fluorescence measurements were acquired for 40 sec fol-
lowed by automatic injection of agonist and the kinetic
measurement of fluorescence intensity was performed for
300 sec. Fura-2 ratio was calculated using Softmax Pro
v5.4.5 and responses measured using area under curve
kinetic reduction.
For simultaneous Fluo-4 and Rhod-2 calcium mea-
surements, J774 cells were plated at a density of 5 × 104
cells/well in complete RPMI 1640 media (100 µL per well)
on poly-D-lysine coated 96-well plates. Cells were loaded
with 2 µM Rhod-2AM in HBSS buffer containing 2mM
probenecid (Fisher Scientific, UK) for 60min at 37 °C.
Loading buffer was removed and replaced with HBSS
containing 2 µM Fluo-4AM and 2mM probenecid. This
was incubated for 40 min at 37 °C. Loading buffer was
removed and replaced with extracellular buffer containing
2mM CaCl2 (zero magnesium) and 1mM probenecid.
Cells were warmed to 37 °C for 10 min in the Flexstation 3
before measurements were started. Fluo-4 fluorescence
was measured at excitation 490 nm and emission 520 nm
(cut-off 515 nm) using 6 reads/well on PMT medium;
Rhod-2 fluorescence was measured at excitation 550 nm
and emission 580 nm (cut-off 570 nm) using 6 reads/well
on PMT medium using a dual wavelength protocol.
Agonists were prepared at 10X final concentration and
automatically injected at 30 sec. Recordings were made for
300 sec in Flex mode allowing analysis of the calcium
signals immediately after injection of agonists +/−
modulators. Following completion of recordings, further
measurements were made in kinetic mode every 60 sec for
90min to follow calcium changes over prolonged time.
Data were collected from three independent experiments
from triplicate wells. Data were analysed by quantifying
the fluorescence change over 300 sec by area under curve
calculations in Softmax Pro software v5.4.5 (normalised
by zero baseline). Kinetic profiles follow absolute fluor-
escence values over the time-course of the experiment.
Membrane potential assays
J774 cells were plated at a density of 2 × 104 cells/well in
complete RPMI 1640 media (100 µL per well) on poly-D-
lysine coated 96-well plates. Cells were left to adhere
overnight. Membrane potential blue (Molecular Devices)
was prepared in standard extracellular buffer. Media was
removed from the plate using a multichannel pipette and
180 µL of membrane potential blue solution added to the
cells. The plate was then incubated at 37 °C in a humi-
dified incubator for 30min. Agonists were prepared at
10X final concentration and added to a drug plate.
Fluorescence was measured using a Flexstation 3 multi-
mode plate reader using excitation wavelength 525 nm
and emission wavelength 565 nm (auto cut-off 550 nm).
PMT setting was medium and 3 reads/well. Each column
was read for 180 sec (2 sec intervals) and then recordings
continued at a sample rate of 1 reading/60 sec for 90min.
Data were collected from three independent experiments
from triplicate wells. Data were then analysed by quanti-
fying the fluorescence change over 180 sec using area
under curve calculations in Softmax Pro software v5.4.5
(normalised by zero baseline).
Lactate dehydrogenase (LDH) assay
LDH release was quantified using a Pierce™ LDH
Cytotoxicity Assay Kit (Fisher Scientific) and was con-
ducted as per manufacturer’s instructions. In brief, 50 µL
of cell supernatant was incubated with 50 µL of the LDH
reaction mixture for 30min at RT prior to measuring
absorbance at 490 nm on a Flexstation 3 plate reader. To
calculate toxicity, the background absorbance (sponta-
neous LDH release) was subtracted from the sample
values. The total amount of LDH contained in the cells
was obtained following lysis of the cells. The LDH
absorbance values obtained from the samples were then
converted and represented as a percentage of the overall
LDH contained within the cells.
Cell viability
Viability experiments were performed using the Cell-
Titer 96® Aqueous Non-Radioactive Cell Proliferation
assay (Promega, UK), a colorimetric method for deter-
mining the number of viable cells. J774 cells were plated
at 2 × 104 cells/well in RPMI 1640 media supplemented
with 1% or 10% serum and left for 24 h under normal
growth conditions. Treatments were then added to the
cells (2× final concentration) and incubated for a further 6
or 24 h. MTS solution (20 µL) was added to media in each
well 4 h before the stipulated end point time. Absorbance
was measured at 490 nm using a Clariostar plate reader
(BMG Labtech, UK) or a Flexstation 3 plate reader.
We also used an AlamarBlue metabolic assay to mea-
sure cell viability. For these experiments resazurin
(0.1 mg/mL in PBS; Sigma–Aldrich) was added to the cells
and incubated for a further 2 h at 37 °C. Fluorescence was
measured on a Flexstation 3 plate reader (excitation,
570 nm; emission, 585 nm). The background fluorescence
of the media alone in the absence of cells was subtracted
from all samples. Data were collected from triplicate wells
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for each experiment and experiments performed three
independent times.
The Multi-tox-fluor multiplex cytotoxicity assay (Pro-
mega, UK) was used, which measures the activity of two
proteases in both live and dead cells. The multi-tox fluor
multiplex cytotoxicity assay was conducted as per man-
ufacturer’s instructions. Equal parts of the viable cell
protease substrate (GF-AFC Substrate) and the dead-cell
protease substrate (bis-AAF-R110 Substrate) were mixed
together in the assay buffer and 100 µL was added to cells
(200 µL [300 µL total volume]) for the final 30 min of
incubation time at 37 °C. Fluorescence was then measured
in a Flexstation 3 (Live-cell fluorescence measured at an
excitation of 400 nm and emission of 505 nm; dead-cell
fluorescence measured at an excitation of 485 nm and
emission of 520 nm).
To inhibit cell death, caspase inhibitors for pan-caspases,
caspase-1, caspase-3, and caspase-8 (Z-VAD-FMK, (Ac-
YVAD-CMK, Z-DEVD-FMK [and Ac-DEVD-CHO], and
Z-IETD-FMK, respectively) or MCC950 were used at 10 µM
and pre-incubated for 2 h prior to stimulation. Inhibitors
were from Santa Cruz (Z-IETD-FMK and Ac-YVAD-CMK)
or Bio-Techne (Z-VAD-FMK, Z-DEVD-FMK, MCC950).
To scavenge mitochondrial ROS, mitoTEMPO (Sigma) was
used at 25 µM, to inhibit Bax the Bax V5 peptide (Bio-
Techne, UK) was used at 200 µM, to chelate Ca2+ EGTA
was used at a concentration of 5mM.
Caspase-3/7 activation
Caspase-3/7 activation in cells was quantified using an
EarlyTox™ Caspase-3/7 NucView 488 kit (Molecular
Devices, UK) according to manufacturer’s instructions.
This method utilises a substrate consisting of a fluoro-
genic DNA dye coupled to the caspase-3/7 DEVD
recognition sequence. When the substrate permeates the
plasma membrane, caspase-3/7 can cleave the substrate,
releasing a high affinity dye that stains the nucleus. In
brief, J774 cells were plated at 2 × 104 cells/well in RPMI
1640 media supplemented with 10% serum or HBSS
(Fisher Scientific, UK) supplemented with 20mM HEPES
and left for 24 h under normal growth conditions.
Treatments were added to the cells (2× final concentra-
tion) and incubated for either 24 h under normal growth
conditions or placed directly in an ImageXpress® Wide-
field system (Molecular Devices, Australia) for 12 h to
measure the kinetics of caspase-3/7 activation. The cas-
pase-3/7 NucView substrate was added to the cells at a
final concentration of 5 µM, incubated at room tem-
perature for 30min, and protected from light. To inhibit
caspase activation, cells were incubated overnight with
10 µM of the pan-caspase inhibitor Z-VAD-FMK (Bio-
Techne, UK). Caspase-3/7-positive cells were observed via
microscopy (FITC filter; Leica, Germany) and caspase-3/7
activation kinetics were quantified using the ImageX-
press® (laser excitation, 500 nm; emission detection,
530 nm). The area of cells was quantified using Fiji
software v.2.
Measurement of reactive oxygen species (ROS)
The production of either cellular ROS or mitochondrial
ROS (mtROS) was quantified using 2’,7’ -dichloro-
fluorescin diacetate (DCFDA; Molecular Probes, UK) or
MitoSOX™ Red reagent (Molecular Probes, Fisher Sci-
entific, UK), respectively. J774 cells were plated at 2 × 104
cells/well (96-well black clear bottom plates) in phenol
red-free RPMI 1640 media supplemented with 10% serum
and left for 24 h under normal growth conditions. For the
quantification of cellular ROS, cells were loaded with a
final concentration of 5 µM DCFDA for 45min at 37 °C
prior to removal of the dye and the addition of treatments
in low divalent assay buffer. DCFDA fluorescence was
detected on a Flexstation 3 plate reader (excitation,
492 nm; emission, 520 nm). For the quantification of
mtROS, cells were loaded with a final concentration of
5 µM MitoSOX™ Red reagent for 10min at 37 °C prior to
removal of the dye and the addition of treatments in low
divalent assay buffer. MitoSOX™ red fluorescence was
detected on a Flexstation 3 plate reader (excitation,
510 nm; emission, 580 nm). Readings were taken every
15min for 60 or 105 min for cellular and mitochondrial
ROS, respectively. Samples were read using PMT low and
either 30 or 50 reads per well for cellular ROS and
mitochondrial ROS, respectively. For the MitoSOX™
assays in the presence of 5 mM EGTA, readings were
taken using kinetic mode on the Flexstation 3 with
readings being taken every 60 sec for 120min.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was quantified
using tetramethylrhodamine methyl ester (TMRM;
Molecular Probes, Fisher Scientific). J774 cells were plated
at 2 × 104 cells/well (96-well plate) in RPMI 1640 media
supplemented with 10% serum and left for 24 h under
normal growth conditions. Cells were stimulated with
their respective treatments for 2, 4, or 24 h in RPMI 1640
media containing 10% serum. The media was replaced
with RPMI 1640 containing 100 nM TMRM for the final
30 min of cell treatment and incubated at 37 °C. Cells
were washed with pre-warmed phenol red-free RPMI and
cells were visualised via fluorescent microscopy (RFP/
TRITC filter, emission detection at 574 nm). The per-
centage of TMRM positive cells was quantified using Fiji
v.2. One image per well was obtained (triplicate wells per
treatment) on a Leica DM16000 inverted microscope
(Hoescht exposure 888.9 ms; TMRM exposure 1.2 s)
using Leica application suite version 2.8.1.
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Statistical analysis
Graphs were plotted using GraphPad Prism version 7
(La Jolla, USA). Concentration-response curves were fit-
ted using a log (agonist) vs response–variable slope (four
parameter) best-fit equation. Error bars are standard
deviation. Data were analysed for statistical significance
using one-way ANOVA or two-way ANOVA with post-
tests as appropriate, including multiple comparisons
testing (GraphPad Prism). Significance was taken as
P < 0.05.
Results
CK potentiates calcium mobilisation, YOPRO-1 uptake
responses, and augments cell death of J774 macrophages
in a P2X7-dependent manner
We have previously reported that CK could positively
modulate P2X715. P2X7 is expressed on J774 cells (Sup-
plementary Fig. 1) and we confirmed that CK potentiates
P2X7-induced Ca2+ responses. Pre-treatment with the
selective P2X7 antagonist AZ10606120 abolished the
ATP+CK mediated Ca2+ response (Fig. 1a, b). Further-
more, CK could enhance both the maximal ATP-induced
Ca2+ response from J774 macrophages and caused a
leftward-shift in the EC50, suggesting an increase in the
sensitivity of cells to ATP (Fig. 1c). A characteristic fea-
ture of P2X7 activation is the formation of a large sec-
ondary pore, which allows impermeant molecules to
traverse the membrane. Upon pore formation, YOPRO-1
can enter the cell, bind to DNA/RNA and fluoresce. CK
could significantly potentiate ATP-induced YOPRO-1 dye
uptake, enhancing both the maximal uptake of YOPRO-1
and reducing the concentration of ATP required to elicit
this response (Fig. 1d, e).
P2X7 can contribute to inflammation via the regulation
of cell death, therefore we investigated the effects of the
positive modulator CK on enhancing macrophage cell
death. It is well established that high concentrations
ofATP in the mM range can induce cell death in
numerous cell types expressing P2X71,2. Following sti-
mulation of J774 cells with a range of ATP concentrations
100 µM to 5 mM, only the 3 mM and 5mM concentra-
tions were capable of eliciting cell death (reducing cell
viability to 29.4% and 38.3% of control, respectively; Fig.
1f, g). This effect could be reversed with AZ10606120
(10 µM) (Fig. 1f, g).
To investigate the effect of CK on potentiation of P2X7-
mediated cell death, we selected 500 µM ATP as it
induces robust responses at P2X7 and is non-lethal (Fig.
1d). CK could not potentiate cell death to ATP con-
centrations lower than this (200 µM; Supplementary Fig.
2). We found that CK could enhance ATP-dependent cell
death in a concentration-dependent manner, with 10 µM
CK causing the most reduction in cell viability after 24 h
(Fig. 2a, b). Moreover, CK had very little effect on cell
viability on its own and therefore required the presence of
ATP to elicit its cytotoxic effects (Fig. 2b). Notably, the
cytotoxic effects of ATP in combination with 10 µM CK
could be reversed by the addition of AZ10606120 (Fig.
2b).
Previous reports state that P2X7 activation in J774
macrophages by high ATP concentrations stimulates cell
death via osmotic lysis, characterised by cell swelling and
rupture17. In agreement, we show that cells exposed to
3mM ATP swell to almost twice the size of cells exposed
to 500 µM ATP and swelling was dependent on P2X7 but
was not dependent on the NLRP3 inflammasome (Fig. 2c)
as pre-treatment with the NLRP3 inhibitor, MCC950, had
no effect (Fig. 2c). Cell swelling induced by 3mM ATP
was associated with a significant increase in the release of
lactate dehydrogenase (LDH), which was not observed
following stimulation of P2X7 by ATP+CK after 24 h
(Fig. 2d).
CK potentiates cell death in a caspase-dependent manner
We investigated whether cell death induced by 3mM
ATP or by ATP+CK was caspase dependent by pre-
incubating with the pan-caspase inhibitor Z-VAD-FMK.
Under these conditions, CK was unable to augment ATP-
induced cell death (Fig. 3a, b), however the lytic cell death
induced by 3mM ATP was largely unaffected (Fig. 3a, b).
We next proceeded to investigate the differences in P2X7-
induced cell death by the two stimuli by using inhibitors
of specific caspases. In order to quantify cell death at an
earlier time-point (6 h) we utilised a multi-tox fluor
cytotoxicity assay allowing us to measure live cells and
dead cells simultaneously. After 6 h ATP+CK increased
cell death by 3.6-fold (Fig. 3c), and this could be inhibited
by AZ10606120. This ATP+CK-induced cell death was
partly reversed by inhibitors for caspase-1, caspase-3, and
MCC950, but not by inhibitors of caspase-8 (Fig. 3c). This
trend was also observed over 24 h, although the effects of
caspase inhibitors did not reach statistical significance
(Fig. 3d). Conversely, death induced by 3mM ATP was
much more pronounced at the 6 h time-point with a 16.8-
fold increase (Fig. 3e) and could not be reversed by any of
the caspase inhibitors tested at either time-point (Fig. 3f).
We measured activation of caspase-3/7 using a Nucview
fluorescent substrate and found ATP+CK could stimu-
late caspase-3/7 activation and this was inhibited by the
caspase-3 inhibitor Ac-DEVD-CHO (Fig. 3g).
Kinetics of caspase-3/7 activation are regulated by P2X7
Numerous studies have implicated a role for P2X7 in
the activation of pro-apoptotic caspases 8, 9, and 34.
Following stimulation of cells with ATP+CK, almost all
the cells were caspase-3/7-positive after 24 h (93.2%)
compared to ~10% for 500 µM ATP alone (Fig. 4a, b).
Moreover, caspase-3/7 activation was inhibited by
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Fig. 1 (See legend on next page.)
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antagonism of P2X7 with a 43% decrease (Fig. 4a, b).
Three millimolar ATP also induced substantial caspase-3/
7 activation after 24 h in a P2X7-dependent manner,
although the percentage of positive cells was lower (76.3%;
Fig. 4a, b). CK alone (10 µM) induced a small increase in
caspase-3/7 activation but this was not significant when
compared to ATP or the vehicle control (Fig. 4a, b). We
observed that cell nuclei were condensing following
treatment with ATP+CK comparable to the effect of
staurosporine, suggesting that cells might be undergoing
classical apoptosis (Fig. 4a). Nuclei area was quantified
using Fiji software (ImageJ) and ATP+CK treated cells
showed a 3-fold reduction (Fig. 4c). In contrast, nuclear
condensation was not observed following stimulation with
3 mM ATP (Fig. 4c).
Treatment of cells with ATP+CK not only maximised
caspase-3/7 activation, it also significantly accelerated
caspase-3/7 activation kinetics measured using a
NucView-488 caspase-3/7 assay. Treatments with ATP
alone, DMSO, 3mM ATP, and staurosporine resulted in
<15% caspase-3/7 activation in the first 8 h of stimulation
(Fig. 4d). Conversely, ATP+CK stimulated caspase-3/7
activation within 30min and led to almost 100% of cells
becoming caspase-3/7-positive within 6 h (Fig. 4d). This
effect was inhibited by AZ10606120 and CK itself did not
elicit significant caspase-3/7 activation in this timeframe
(Fig. 4d).
CK can potentiate the generation of mitochondrial reactive
oxygen species (mtROS) and loss of mitochondrial
membrane potential
Based on the rapid activation of caspase-3/7, cell
shrinking and nuclei condensation, it would seem likely
that the route of cell death induced by ATP+CK could
be apoptotic. Apoptosis can be induced by a large number
of extrinsic and intrinsic signals, including reactive
nitrogen species, DNA damage, hypoxia, serum depriva-
tion, and pathogenic challenge18. Moreover, the exposure
to xenobiotics, such as pesticides, chemotherapeutic
drugs, and phytochemicals, can trigger apoptosis, which
are often mediated by reactive oxygen species (ROS)19.
We first quantified the production of cellular ROS in
response to P2X7 activation using the fluorescent indi-
cator DCFDA. Here we observed that stimulating J774
macrophages with ATP+CK did not induce a significant
increase in DCFDA fluorescence over 60min compared to
3mM ATP or CK alone (Fig. 5a, b) whereas the positive
control (hydrogen peroxide) enhanced cellular DCFDA
fluorescence. ATP+CK and 3mM ATP-induced changes
in DCFDA were not affected by AZ10606120 suggesting
P2X7 does not contribute to cellular ROS production (Fig.
5a, b).
Mitochondrial ROS (mtROS) can stimulate an increase
in mitochondrial membrane permeability, which allows
the release of pro-apoptotic molecules such as cyto-
chrome c and apoptosis-inducing factor into the cytosol.
We therefore investigated changes in the production of
mtROS and in mitochondrial membrane potential.
mtROS was quantified over a 105 min stimulation period
using mitoSOX and the combination of ATP+CK was
capable of inducing an almost 4-fold increase in the
production of mtROS compared to ATP alone (Fig. 5c, d).
Unlike cellular ROS production, the potentiation of
mtROS production by CK appeared to be predominantly
regulated by P2X7, as inhibition of P2X7 reduced mtROS
back to baseline values (Fig. 5c, d). Furthermore, akin to
the caspase-3/7 observations, CK not only influenced the
magnitude of mtROS generation, but also accelerated the
production of mtROS (Fig. 5c). MtROS production was
also induced by 3mM ATP, although the rate of pro-
duction was delayed compared to ATP+CK (Fig. 5c, d).
Changes in mitochondrial membrane potential were
quantified using TMRM. Following stimulation with
500 µM ATP over 24 h, a high level of mitochondrial
fluorescence was observed, indicating that TMRM was
being retained in mitochondria and the membrane
potential remained intact (Fig. 5e, f). Conversely, addition
of ATP+CK, 3 mM ATP, or staurosporine resulted in a
significant loss of TMRM fluorescence over time, indi-
cating a loss of mitochondrial membrane potential (Fig.
5e, f). Mitochondrial membrane collapse by ATP+CK
and 3mM ATP, could be completely inhibited by
AZ10606120 (Fig. 5e, f). Kinetically, 3 mM ATP could
induce loss of mitochondrial membrane potential faster
(see figure on previous page)
Fig. 1 Compound K (CK) potentiates P2X7 responses. a J774 macrophages were stimulated with 200 µM ATP in the presence or absence of CK or
CK+ AZ10606120 (both 10 µM) and Ca2+-responses were quantified using Fura-2. b The sustained response (100-200 sec) was quantified as an
indicator of P2X7-dependent responses. c J774 macrophages were stimulated with a range of ATP concentrations in the presence or absence of CK
(10 µM) prior to quantification of the Fura-2 sustained response as in b. c J774 macrophages were stimulated with 500 µM ATP in the presence or
absence of AZ10606120 (10 µM) to quantify uptake of YOPRO-1 dye. d YOPRO-1 dye uptake by J774 macrophages to a range of ATP concentrations
in the presence or absence of CK (10 µM). f Cell viability of J774 macrophages stimulated with a range of macrophages in the presence or absence of
AZ10606120 (10 µM) and quantified using AlamarBlue. g Light micrograph demonstrating the morphology of cells treated with 3 mM ATP in the
presence or absence of AZ10606120 (10 µM). Experiments are representative of three independent experiments (n= 3). Error bars represent SD.
Asterisks represent a significant difference (p < 0.05). Scale bars are 50 µm.
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than ATP+CK, with 26.6% of cells losing membrane
potential compared to 3.6% after 2 h stimulation, respec-
tively. By 4 h the percentage of cells losing membrane
potential increased to 58.1% and 68% for ATP+CK and
3mM ATP, respectively. After 24 h, the loss of membrane
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Fig. 2 CK potentiated cell death is morphologically different to death induced by 3mM ATP. a Light micrographs of J774 cells stimulated with
500 µM ATP alone or in the presence of various treatments (CK and AZ10606120 both 10 µM). b J774 cells were stimulated with decreasing
concentrations of CK (10–1 µM) in combination with 500 µM ATP or alone. AZ10606120 was used at a concentration of 10 µM and cell death
quantified by AlamarBlue. c J774 cells were stimulated with various treatments and the area of the cells after 3 h was quantified using Fiji. d LDH
release following a 6 h stimulation with various treatments. Experiments are representative of three independent experiments (n= 3). Error bars
represent SD. Asterisks represent a significant difference (p < 0.05). Scale bars are 50 µm.
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(see figure on previous page)
Fig. 3 CK promotes cell death in a caspase-dependent manner but death induced by 3mM ATP could not be blocked by caspase
inhibitors. a Light micrographs depicting J774 cells pre-incubated with the pan-caspase inhibitor Z-VAD-FMK (10 µM) prior to stimulation with
500 µM ATP, 500 µM ATP+ CK, CK alone, or 3 mM ATP. b Cell viability of J774 cells stimulated with the treatments outlined in a. c J774 cells were pre-
incubated with inhibitors towards caspase-1, caspase-3, caspase-8, or MCC950 (all 10 µM) and challenged with ATP+ CK (10 µM) for 6 h, prior to
quantification of a protease released by dead cells. d J774 cells were pre-incubated with inhibitors towards caspase-1, caspase-3, caspase-8, or
MCC950 (all 10 µM) and challenged with ATP+ CK (10 µM) for 24 h, prior to quantification of cell death by Alamar Blue. e J774 cells were pre-
incubated with inhibitors towards caspase-1, caspase-3, caspase-8, or MCC950 (all 10 µM) and challenged with 3 mM ATP for 6 h, prior to
quantification of a protease released by dead cells. f J774 cells were pre-incubated with inhibitors towards caspase-1, caspase-3, caspase-8, or
MCC950 (all 10 µM) and challenged with 3 mM ATP for 24 h, prior to quantification of cell death by Alamar Blue. g Fluorescent micrographs of J774
cells stimulated for 24 h with various treatments in the presence or absence of the caspase-3/7 inhibitor Ac-DEVD-CHO (10 µM). Caspase-3/7
activation was quantified using an EarlyTox™ Caspase-3/7 NucView 488 kit. Experiments are representative of three independent experiments (n= 3).
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Fig. 4 CK accelerates caspase-3/7 activation and promotes nuclear condensation in a P2X7-dependent manner. a J774 cells were stimulated
for 24 h with 500 µM ATP alone, or in combination with CK or CK and AZ10606120 (both 10 µM), with 3 mM ATP or with CK alone. Staurosporine
(5 µM) was used as a positive control. b The percentage of caspase-3/7 cells following each treatment after 24 h was quantified from fluorescent
micrographs using Fiji. c The relative area of the caspase-3/7-positive cells from a, b was quantified using Fiji. d The kinetics of caspase-3/7 activation
was reported following quantification of the caspase-3/7-positive cells every hour for 12 h using an ImageXpress. Experiments are representative of
three independent experiments (n= 3). Error bars represent SD. Asterisks represent a significant difference (p < 0.05). Scale bars are 50 µm.
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and 86.7% of cells losing membrane potential following
stimulation with ATP+CK or 3mM ATP, respectively
(Fig. 5f).
Cell death and loss of mitochondrial membrane potential
induced by ATP+ CK can be reduced by inhibiting Bax and
scavenging mtROS
We explored the mechanisms underlying mtROS gen-
eration and the loss of mitochondrial membrane potential
correlated with differential cell death outcomes following
P2X7 activation using mitoTEMPO as a scavenger of
mtROS and a Bax inhibitory peptide to prevent Bax
activation. After a 6 h incubation with ATP+CK, cell
death could be completely inhibited by mitoTEMPO or
the Bax inhibitory peptide (Fig. 6a). Over prolonged sti-
mulations, mitoTEMPO could inhibit cell death to a
similar level as AZ10606120, suggesting that mtROS was
one of the early triggers of cell death under these
conditions. However, the Bax inhibitor could not inhibit
cell death as effectively after 24 h of stimulation (Fig. 6b).
Conversely, neither mitoTEMPO nor the Bax inhibitory
peptide could inhibit cell death induced by 3mM ATP
following either a 6 h or 24 h stimulation (Fig. 6c, d).
These observations were also extended to mitochondrial
membrane potential. Following 4 h of stimulation with
ATP+CK, ~50% of cells had completely lost mitochon-
drial membrane potential (no TMRM fluorescence) and
this was inhibited by mitoTEMPO and inhibition of Bax
(Fig. 6e, f). Neither mitoTEMPO nor Bax inhibitory
peptide could inhibit the loss of mitochondrial membrane
potential elicited by 3 mM ATP (Fig. 6g, h).
P2X7 stimulated increases in mitochondrial Ca2+
contribute to mtROS production and cell death
Ca2+ plays an important role in regulating numerous
biological processes, including the induction of mtROS.
Fig. 5 CK potentiates mtROS and loss of mitochondrial membrane potential but not cellular ROS generation. a J774 cells were pre-incubated
with 5 µM DCFDA prior to the respective treatments and DCFDA fluorescence was measured every 15 min for 1 h. b The relative amount of DCFDA
fluorescence as calculated by percentage change from the baseline fluorescence after 1 h, following the treatments in a. c J774 cells were pre-
incubated with 5 µM mitoSOX prior to the respective treatments and mitoSOX fluorescence was measured every 15 min for 105 min. d The relative
amount of mitoSOX fluorescence as calculated by percentage change from the baseline fluorescence after 105 min, following the treatments in c.
Experiments are representative of three independent experiments (n= 3). Error bars represent SD. Asterisks represent a significant difference (p <
0.05). e J774 cells were stimulated for 4 h with 500 µM ATP alone, or in combination with CK or CK and AZ10606120 (both 10 µM), with 3 mM ATP ±
AZ10606120, or with CK alone. Staurosporine (5 µM) was used as a positive control. Cells were incubated with TMRM (100 nM) for the final 30 min of
the treatment time (4 h or 24 h) and fluorescent images were taken. f The percentage of cells positive for TMRM was identified by quantifying the
number of cells positive for TMRM fluorescence in Fiji. Experiments are representative of three independent experiments (n= 3). Error bars represent
SD. Asterisks represent a significant difference (p < 0.05). Scale bars are 50 µm.
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Therefore, we investigated the effect of Ca2+ influx on the
generation of mtROS and mechanism of cell death. We
first measured the total inward movement of charged ions
(depolarisation) across the plasma membrane of J774 cells
following stimulation of P2X7 with ATP+CK by utilising
a cellular membrane potential kit. Activation of P2X7 by
ATP+CK or 3 mM ATP evoked a large membrane
depolarisation due to the inward flux of cations through
open P2X7 channels (Fig. 7a). Measuring the first 180 sec
of P2X7 activation revealed a larger depolarisation
response amplitude to 3 mM ATP than to ATP+CK (Fig.
7b). Continued measurement of plasma membrane
potential over 90min revealed that the ATP+CK
response was significantly shorter in duration than the
3mM ATP-induced response with the mean time taken
to fall from 90% to 10% response being 1820 sec
(30.3 min) compared with 3740 sec (62.3 min) for 3 mM
ATP (Fig. 7a, c). However, specifically measuring intra-
cellular Ca2+ concentrations in cytosolic and mitochon-
drial compartments with Fluo-4 and Rhod-2 Ca2+
indicator dyes, respectively, identified that the cytosolic
elevations in Ca2+ and mitochondrial uptake were sig-
nificantly greater following the application of ATP+CK
compared to 3 mM ATP (Fig. 7d–i). Continued mea-
surement of Ca2+ elevations in cytosol and mitochondria
over 90min revealed larger and more sustained elevations
in Ca2+ with ATP+CK (Fig. 7c–i).
Enhanced mitochondrial Ca2+ can be a trigger to pro-
duce mtROS, and mtROS appeared to be the trigger for
cell death induced by positive modulation of P2X7. Che-
lation of extracellular Ca2+ using EGTA resulted in both a
decreased and delayed induction of mtROS by ATP+CK
but did not affect the slower production of mtROS fol-
lowing stimulation with 3 mM ATP (Fig. 7j). Focusing on
data obtained at the 30 min time-point showed that
removing Ca2+ could significantly abrogate the quick
onset of mtROS generation by ATP+CK but not 3 mM
ATP (Fig. 7k). Chelating extracellular Ca2+ could sig-
nificantly inhibit the cell death induced by 3mM ATP, but
inhibited the cell death induced by ATP+CK to a greater
extent after 6 h suggesting that Ca2+ plays a critical role in
CK-potentiated apoptosis (Fig. 7m).
Discussion
Our study focused on understanding the mechanism of
cell death induced following positive allosteric modula-
tion of the ATP-gated ion channel, P2X7. As a result, we
demonstrated several findings. Notably, high millimolar
ATP concentrations stimulated an unregulated form of
cell death, which could not be stopped by inhibiting
caspases, blocking Bax, or by scavenging mtROS, and was
characterised by early cell swelling and cell lysis. Con-
versely, the combination of ATP and CK induced a sig-
nificant increase in mitochondrial Ca2+, which was
accompanied by accelerated mtROS production, acceler-
ated caspase-3/7 activation, and cell death that can be
partly inhibited by caspase inhibitors, inhibition of Bax,
removal of extracellular Ca2+, or mtROS scavenging (Fig. 8).
Maximal ATP (3 mM) could elicit a large movement of
charged ions (depolarisation) but CK-induced potentia-
tion of P2X7 appeared to selectively increase Ca2+ influx
and intracellular Ca2+ concentrations, notably enhancing
mitochondrial Ca2+. We have previously reported in
detail that CK can act as a positive allosteric modulator of
P2X7 receptors15,16. Utilising a molecular modelling and
mutagenesis approach we recently identified an allosteric
pocket within the central vestibule of P2X7. However, it is
still currently poorly understood how binding to this
novel binding pocket enhances ion channel activity,
macropore formation, or how CK modulates ion
permeability15,16.
It is well established that P2X7 can participate in the
regulation of cell death, with high concentrations of ATP
inducing necrotic, pyroptotic, or apoptotic cell death
depending on the stimulatory factors present, the incu-
bation time, and the cell type3,11,20,21. Previous reports
state that P2X7 activation stimulates cell death in J774
macrophages via colloido-osmotic lysis, characterised by
(see figure on previous page)
Fig. 6 Scavenging mtROS or inhibiting Bax can prevent cell death and loss of mitochondrial membrane potential following stimulation
with ATP+ CK but not by 3mM ATP. a J774 cells were pre-incubated with the mtROS scavenger mitoTEMPO (25 µM) or the Bax V5 inhibitor
peptide (200 µM) and challenged with ATP+ CK (10 µM) for 6 h, prior to quantification of a protease released by dead cells. b or a 24 h stimulation
prior to quantification of cell death by AlamarBlue. c J774 cells were pre-incubated with the mtROS scavenger mitoTEMPO or the Bax V5 inhibitor
peptide and challenged with 3 mM ATP for 6 h, prior to quantification of a protease released by dead cells. d or a 24 h stimulation prior to
quantification of cell death by by AlamarBlue. e Fluorescent micrographs of J774 cells pre-incubated with the mtROS scavenger mitoTEMPO or the
Bax V5 inhibitor peptide and challenged with ATP+ CK for 4 h, prior to incubation with TMRM (100 nM) for the final 30 min of the treatment time to
measure mitochondrial membrane potential. f The percentage of cells positive for TMRM after stimulation with ATP+ CK was identified by
quantifying the number of cells positive for TMRM fluorescence in Fiji. g Fluorescent micrographs of J774 cells pre-incubated with the mtROS
scavenger mitoTEMPO or the Bax V5 inhibitor peptide and challenged with 3 mM ATP for 4 h, prior to incubation with TMRM (100 nM) for the final
30 min of the treatment time to measure mitochondrial membrane potential. h The percentage of cells positive for TMRM after stimulation with
3mM ATP was identified by quantifying the number of cells positive for TMRM fluorescence in Fiji. Experiments are representative of three
independent experiments (n= 3). Error bars represent SD. Asterisks represent a significant difference (p < 0.05). Scale bars are 50 µm.
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cell swelling and rupture17. Concordant with these
observations, J774 cells treated with 3 mM ATP swelled to
almost twice the size and appeared to rupture, based on
the detection of LDH in the cell supernatant. Moreover,
this lytic cell death could not be inhibited by caspase
inhibitors, mtROS scavenging, or Bax inhibition. How-
ever, chelation of extracellular Ca2+ could prevent some
of the cell death induced by 3mM ATP, which suggests
the large movement of ions and divergence from the
osmotic equilibrium are likely key contributors to this
form of cell death.
Conversely, the fast increase in mitochondrial Ca2+ and
subsequent production of mtROS seem to be critical
triggers in the induction of cell death following stimula-
tion with ATP+CK. The accelerated kinetics of mtROS
are correlated with caspase-3/7 activation and likely
occurs because of the loss of mitochondrial membrane
integrity induced by mtROS or via release of pro-
apoptotic factors through Bax channels. Moreover, this
form of cell death was caspase-dependent, and the pan-
caspase inhibitor could limit cell death. Inhibition of
individual caspases had less of an effect but the NLRP3
inflammasome, caspase-1, and caspase-3 were implicated.
MtROS production is linked to activation of the NLRP3
inflammasome22, and caspase-1 has recently been identi-
fied to activate caspase-323. Additional activation of
caspase-3 by caspase-1 could explain why activation of
caspase-3/7 was so significantly accelerated, but this is
something that would need to be explored further.
There is growing evidence that ROS and mitochondria
play an important role in stimulating apoptosis, whilst
mitochondria are also both a target and source of ROS19.
P2X7 activation has been implicated in the generation of
ROS in macrophages and microglia, which could be
inhibited by P2X7 antagonists including oxidized ATP,
Brilliant Blue G, and AZ106061205,24,25. In contrast to
Fig. 7 CK+ ATP stimulates the accumulation of Ca2+ in the mitochondria which is critical for mtROS generation and apoptotic cell death.
a Kinetic analysis quantifying the movement of charged ions across the cell membrane over two time periods totalling 6000 sec, following
stimulation with ATP+ CK or 3 mM ATP. b The initial movement of charged ions as quantified by area under the curve from 0–180 sec. c The time
taken for the response to decrease from 90% of the maximal response to 10% of this depolarisation response. d The measurement of intracellular Ca2+
by quantification of Fluo-4 fluorescence over two time periods totalling 6000 s following stimulation with ATP+ CK or 3 mM ATP. e The initial
measurement of intracellular Ca2+ as quantified by area under the curve from 0–300 sec. f The peak Fluo-4 fluorescence reached over the 6000 sec
time-period. g The measurement of mitochondrial Ca2+ by quantification of Rhod-2 fluorescence over two time periods totalling 6000 sec following
stimulation with ATP+ CK or 3 mM ATP. h The initial measurement of mitochondrial Ca2+ as quantified by area under the curve from 0–300 sec. i
The peak Rhod-2 fluorescence reached over the 6000 s time-period. j mtROS production was measured using mitoSOX every 60 sec for 120 min
following stimulation with ATP alone, ATP+ CK, or 3 mM ATP in the presence or absence of 5 mM EGTA. k The % increase of mtROS generation from
baseline level after 30 min in the presence or absence of EGTA following stimulation with ATP+ CK, or c 3 mM ATP. l light micrographs depicting cell
death in the presence or absence of EGTA and respective stimulations. m Cell death induced by ATP+ CK or 3 mM ATP in the presence of Ca2+
compared to when Ca2+ is chelated by EGTA. All experiments are representative of three independent experiments (n= 3). Error bars represent SD.
Asterisks represent a significant difference (p < 0.05). Scale bars are 50 µm.
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cellular ROS, P2X7 activation and Ca2+ were critical in
the generation of mtROS following stimulation with ATP
and CK. Notably, ATP and CK could stimulate an instant
spike in mtROS production and upon removal of Ca2+ or
inhibition of P2X7, this initial spike was lost, and cells
survived.
ROS initiate the intrinsic pathway of mitochondria and
promote the activation of pro-apoptotic proteins26–28. An
increase in the production of mtROS, particularly by
hydrogen peroxide, has previously been directly linked
with collapse of mitochondrial membrane potential29–31.
P2X7 has been implicated in stimulating mitochondrial
dysfunction and membrane collapse in response to large
increases in intracellular Ca2+ accumulation. The sub-
sequent loss of mitochondrial membrane potential and
increase in mitochondrial membrane permeability has
been implicated in the release of numerous pro-apoptotic
factors such as apoptosis-inducing factor and cytochrome
c, which contributes to formation of the apoptosome
complex, activation of caspase-3, and ultimately apopto-
sis32–34. Therefore, by reducing the amount of Ca2+
available to enter the cell, we have limited the ability of
ATP and CK to promote the steps necessary to evoke
early mtROS production, thus removing the initial trigger
and the ability of CK to promote cell death.
To conclude, CK potentiation of P2X7-dependent
responses promotes the induction of the intrinsic path-
way of apoptosis via an increase in mitochondrial Ca2+,
accelerated production of mtROS, loss of mitochondrial
membrane potential, and accelerated caspase-3/7 activa-
tion while activation with high ATP concentrations
induces an early caspase-independent lytic cell death
pathway. This provides evidence that allosteric modula-
tion of P2X7 can be exploited to calibrate cell death
outcomes. Positive allosteric modulation of P2X7 recep-
tors opens various avenues of exploration; such as whe-
ther it can enhance the killing of intracellular pathogens,
augment the removal of P2X7 expressing cancer cells, or
contribute to the resolution of inflammation.
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